Search the Archive

Commercial: CYP3A4 / Ubrelvy #1387871

FNC Evening News for Tuesday, May 31, 2022
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws.

Ubrelvy helps you fight migraine attacks. You put it all on the line. You do it all, so you bring you ground. It can quickly stop migraine in its tracks within 2 hours without worrying if it's too late or where you are. Unlike older medicines, ubrelvy is a pill that directly blocks a protein believed to be a cause of migraine. Do not take with strong CYP3A4 inhibitors. Most common side effects were nausea and tiredness. Migraine pain relief starts with you. Learn how AbbVie can help you see. As...

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

  • You may request a loan of this video by registering on our website and placing an order.
  • You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
  • If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.